Boothbay Fund Management, LLC Axsome Therapeutics, Inc. Put Options Transaction History

Boothbay Fund Management, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $327,096 - $505,959	5,600 Added 17.89%	36,900 $2.65 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $6.4 Million - $8.22 Million	-109,600 Reduced 77.79%	31,300 $1.93 Million
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $39,940 - $79,720	-1,000 Reduced 0.7%	140,900 $10.9 Million
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $5.09 Million - $9.86 Million	-141,100 Reduced 49.86%	141,900 $6.33 Million
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $1.88 Million - $4.05 Million	-86,600 Reduced 23.43%	283,000 $10.8 Million
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $4.94 Million - $8.62 Million	208,300 Added 129.14%	369,600 $15.3 Million
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $1.74 Million - $2.46 Million	56,800 Added 54.35%	161,300 $6.09 Million
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $2.08 Million - $7.13 Million	104,500 New	104,500 $3.44 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.59B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.